Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myasthenia Gravis, Generalized”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Testing effectiveness (Phase 2)Study completedNCT02473952
What this trial is testing

Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Grifols Therapeutics LLC 62
Post-approval studies (Phase 4)Looking for participantsNCT07072988
What this trial is testing

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

Who this might be right for
Myasthenia Gravis, Generalized
Centre Hospitalier Universitaire de Nice 50
Testing effectiveness (Phase 2)Looking for participantsNCT06987539
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

Who this might be right for
Generalized Myasthenia Gravis
Amgen 15
Large-scale testing (Phase 3)Looking for participantsNCT04951622
What this trial is testing

Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Janssen Research & Development, LLC 199
Testing effectiveness (Phase 2)Looking for participantsNCT07284420
What this trial is testing

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Who this might be right for
AChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia GravisMG+3 more
argenx 70
Large-scale testing (Phase 3)Looking for participantsNCT06587867
What this trial is testing

Seronegative Myasthenia Gravis - Efgartigimod IV

Who this might be right for
EfgartigimodGeneralized Myasthenia Gravis
University Health Network, Toronto 30
Very early researchNot Yet RecruitingNCT06485232
What this trial is testing

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia Gravis, GeneralizedMultiple Sclerosis+1 more
Xuanwu Hospital, Beijing 25
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Large-scale testing (Phase 3)Looking for participantsNCT06447597
What this trial is testing

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

Who this might be right for
Generalized Myasthenia Gravis
Shanghai Jiaolian Drug Research and Development Co., Ltd 104
Large-scale testing (Phase 3)Study completedNCT04115293
What this trial is testing

Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Ra Pharmaceuticals, Inc. 174
Not applicableLooking for participantsNCT07411963
What this trial is testing

Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis

Who this might be right for
Myasthenia Gravis
Centre Hospitalier Universitaire de Nice 30
Large-scale testing (Phase 3)Study completedNCT04124965
What this trial is testing

Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 71
Post-approval studies (Phase 4)Looking for participantsNCT07246564
What this trial is testing

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
UCB Biopharma SRL 40
Large-scale testing (Phase 3)Looking for participantsNCT06456580
What this trial is testing

Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Who this might be right for
Generalized Myasthenia Gravis
Vor Biopharma 180
Large-scale testing (Phase 3)Looking for participantsNCT06607627
What this trial is testing

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Study completedNCT06764160
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG

Who this might be right for
Generalized Myasthenia Gravis (gMG)Refractory gMG
Alexion Pharmaceuticals, Inc. 15
Large-scale testing (Phase 3)Looking for participantsNCT04833894
What this trial is testing

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
argenx 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05556096
What this trial is testing

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 261
Testing effectiveness (Phase 2)Study completedNCT01480596
What this trial is testing

The Evaluation of Belimumab in Myasthenia Gravis (MG)

Who this might be right for
Myasthaenia Gravis
GlaxoSmithKline 40
Large-scale testing (Phase 3)Study completedNCT05039190
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients

Who this might be right for
Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd. 132
Load More Results